← 홈

CGT · 혈액암 (AML/ALL)

383개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 383개
CGTBiologicstaleCoronado Biosciences, Inc.Phase 2

Allogeneic natural killer cells (Allogeneic natural killer cells)

Fallopian Tube Cancer; Ovarian Cancer · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase2#인기#세포유전치료+5
효능 ORR 5%임상시험 57상태 DISCONTINUED
CGTBiologicstaleImmunityBio, Inc.Phase 2

ALT-803 (ALT-803)

Melanoma · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase2#인기#세포유전치료+5
효능 ORR 33%임상시험 56상태 DISCONTINUED
CGTBiologicstaleMarzieh EbrahimiPhase 1

Allogenic NK cells infusion (Allogenic NK cells infusion)

Neuroblastoma, Recurrent, Refractory; Neuroblastoma (NB) · FRα

#FR#CGT#Phase1#인기#세포유전치료+5
효능 ORR 5%임상시험 56상태 RECRUITING
CGTBiologicstaleYake Biotechnology Ltd.Phase 1

CD19/CD22 CAR T-Cells (CD19/CD22 CAR T-Cells)

Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#인기#세포유전치료+5
임상시험 54상태 RECRUITING
CGTBiologicstaleShenzhen Hornetcorn Bio-technol…Preclinical

CIK cell therapy (CIK cell therapy)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#CGT#Preclinical#인기#세포유전치료+4
임상시험 54상태 ACTIVE
CGTBiologicstaleNovartis PharmaceuticalsPhase 2

cytogenetic analysis (cytogenetic analysis)

Chronic Myeloproliferative Disorders; Leukemia · Colorectal Cancer

#ColorectalCancer#CGT#Phase2#인기#세포유전치료+5
임상시험 54상태 ACTIVE
CGTBiologicstaleMatthew FrankPhase 1

CD22 CAR (CD22 CAR)

B-ALL; B-cell Non Hodgkin Lymphoma · CD22

#CD22#CGT#Phase1#인기#세포유전치료+5
임상시험 53상태 ACTIVE
CGTBiologicstaleHebei Senlang Biotechnology Inc…Phase 1

CD22 CAR-T (CD22 CAR-T)

Childhood Acute Lymphoblastic Leukemia · CD22

#CD22#CGT#Phase1#인기#세포유전치료+5
임상시험 53상태 ACTIVE
CGTBiologicstaleiCell Gene TherapeuticsPhase 1

CD7 CAR T-cells (CD7 CAR T-cells)

T-cell Acute Lymphoblastic Leukemia; T-cell Acute Lymphoblastic Lymphoma · Crohn Disease

#CrohnDisease#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 49상태 ACTIVE
CGTBiologicstaleBiohaven Pharmaceuticals, Inc.Phase 3

Autologous cytokine-induced killer cell (Autologous cytokine-induced killer cell)

Non-small Cell Lung Cancer · Small Cell Lung Cancer

#SmallCellLungCancer#CGT#Phase3#세포유전치료#CAR-T+4
임상시험 46상태 ACTIVE
CGTBiologicstaleAcrotech Biopharma Inc.Vedotin, and BelinostatPhase 1

Belinostat (Belinostat)

Breast Adenocarcinoma; Metastatic Breast Carcinoma · Adult T-cell Leukemia-Lymphoma

#AdultT-cellLeukemia-Lymphoma#CGT#Phase1#세포유전치료#CAR-T+5
효능 ORR 25%임상시험 45상태 DISCONTINUED
CGTBiologicstaleNovartisPhase 3

tisagenlecleucel (Kymriah, tisa-cel)

Acute Lymphoblastic Leukemia · FRα

#FR#CGT#Phase3#세포유전치료#CAR-T+4
효능 ORR 83.3%임상시험 45상태 DISCONTINUED
CGTBiologicstaleIncyte CorporationPhase 2

pentostatin (pentostatin)

Chronic Myeloproliferative Disorders; Leukemia · Chronic Myeloproliferative Disorders

#ChronicMyeloproliferativeDisorde#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 96%임상시험 45상태 DISCONTINUED
CGTBiologicstaleInnovative Cellular Therapeutic…calicheamicin, may impact C…Phase 2

CART-19 (CART-19)

Acute Lymphocytic Leukemia · B Cell Leukemia

#BCellLeukemia#CGT#Phase2#세포유전치료#CAR-T+5
효능 ORR 43.8%임상시험 44상태 ACTIVE
CGTBiologicstaleOHSU Knight Cancer InstitutePhase 2

Hyper-CVAD (Hyper-CVAD)

Relapsed/Refractory; B-cell Acute Lymphocytic Leukemia · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+5
효능 ORR 89%임상시험 40상태 RECRUITING
CGTBiologicstalejiuwei cuiPhase 1

CD19-targeted CART cells (CD19-targeted CART cells)

Leukemia, B-Cell · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 39상태 ACTIVE
CGTBiologicstaleHebei Senlang Biotechnology Inc…Phase 1

CD123 CAR-T cells (CD123 CAR-T cells)

Acute Myelocytic Leukemia · Acute Myelocytic Leukemia

#AcuteMyelocyticLeukemia#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 37상태 ACTIVE
CGTBiologicstaleNovartis PharmaceuticalsPhase 2

CTL019 T-cells (CTL019 T-cells)

B-cell Acute Lymphoblastic Leukemia; Relapsed B-cell Acute Lymphoblastic Leukemia · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+5
효능 ORR 82.3%임상시험 37상태 ACTIVE
CGTBiologicstaleBristol Myers Squibbvedotin plus bendamustine a…Phase 2

lisocabtagene maraleucel (JCAR017, JCAR017 (lisocabtagene maraleucel))

Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Small Lymphocytic · Leukemia, Lymphocytic, Chronic, B-Cell

#LeukemiaLymphocyticChronicB-Cell#CGT#Phase2#세포유전치료#CAR-T+5
효능 ORR 80.5%임상시험 34상태 RECRUITING
CGTBiologicstaleBristol Myers Squibbvedotin plus bendamustine a…Phase 2

JCAR017 (JCAR017, JCAR017 (lisocabtagene maraleucel) + ibrutinib, lisocabtagene maraleucel)

Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Small Lymphocytic · Leukemia, Lymphocytic, Chronic, B-Cell

#LeukemiaLymphocyticChronicB-Cell#CGT#Phase2#세포유전치료#CAR-T+5
효능 ORR 80.5%임상시험 34상태 RECRUITING

2 / 20 페이지

← 이전다음 →